Currently Browsing

Our Products

Fesoterodine Fumarate Extended-Release Tablets 8 mg – 30/Bottle

Overview

Reference Brand:
Toviaz®
Therapeutic Class:
Fesoterodine

Specifications

GCN:
99712
Strength:
8 mg
Size:
30
NDC #:
65862076730
TE Code:
AB

Order Information

Case Qty (min order qty):
48
Case Weight (lbs):
4.768

Attributes

Physical Form:
Tablets
Shape:
Tablets
Color:
Blue
Imprint:
"K47"
Prescribing Info
Product News

March 31, 2025 | Aurobindo Receives FDA Approval for Pantoprazole Sodium for Delayed-Release Oral Suspension, 40 mg ... Read more

Product News

March 21, 2025 | Aurobindo Receives FDA Approval for Nystatin Cream USP, 100,000 units per gram ... Read more

Product News

February 27, 2025 | Aurobindo Receives FDA Approval for Tretinoin Gel USP, 0.025% ... Read more